IDO1 and melanoma: Recently, the subset of melanoma tumors characterized by the presence of T-cell infiltrates was found to demonstrate activation of three immunosuppressive markers: indoleamine-2,3-dioxygenase (IDO), PD-L1, and FoxP3+ regulatory T cells (Tregs).